Topical analgesic
OwnerTony LaRosa, Robert Davidson +1inventors
InventorsTony LaRosa, Robert Davidson, David Reid
Life of this patent
Estimating the term…
Abstract
Provided herein is a topical analgesic composition that includes an external analgesic agent, one or more pharmaceutically acceptable excipients, and at least one of a cannabinoid, terpene, and flavonoid. Also provided is a method that includes topically administering to a skin surface of a subject (e.g., human) the topical analgesic composition.
Claims15
A method for the temporary relief of aches or pains of affected muscles or joints areas, the method comprising topically administering to the affected areas of a subject in need thereof a topical analgesic comprising:
- menthol, present in 2.5±0.5 wt. %;
- cannabidiol (CBD), present in 0.33±0.07 wt. %;
- carbopol, present in 1.4±0.3 wt. %;
- lecithin, present in 2±0.4 wt. %;
- caffeine anhydrous, present in 1.5±0.3 wt. %;
- salicin, in an amount consisting of 1.25±0.25 wt. %;
- organic hemp oil, present in 1±0.2 wt. %;
- sodium benzoate, present in 0.1±0.02 wt. %,
- tocopheryl acetate, present in 0.2±0.04 wt. %,
- sodium bicarbonate, present in 1.5±0.3 wt. %;
- and
- water, present in 88.22±5 wt. %;
- wherein,
- the topical analgesic is configured and formulated as a cream, lotion, or roll-on liquid.
A method for the temporary relief of aches or pains of affected muscles or joints areas, the method comprising topically administering to the affected areas of a subject in need thereof a topical analgesic comprising:
- menthol, present in 2.5±0.5 wt. %;
- cannabidiol (CBD), present in 0.33±0.07 wt. %;
- carbopol, present in 1.4±0.3 wt. %;
- lecithin, present in 2±0.4 wt. %;
- caffeine anhydrous, present in 1.5±0.3 wt. %;
- salicin, in an amount consisting of 1.25±0.25 wt. %;
- organic hemp oil, present in 1±0.2 wt. %;
- sodium benzoate, present in 0.1±0.02 wt. %;
- tocopheryl acetate, present in 0.2±0.04 wt. %;
- sodium bicarbonate, present in 1.5±0.3 wt. %;
- water, present in 88.22±5 wt. %;
- optionally cannabigerol (CBG);
- optionally isopropyl alcohol;
- wherein,
- the topical analgesic is configured and formulated as a cream, lotion, or roll-on liquid;
- and
- the cannabidiol (CBD) is obtained from cannabis as a CBD distillate, a CBD isolate, or a combination thereof.
Dependencies are inferred from the claim text.